Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changhoon Yoo

Showing results (101-110 of 250) with videos related to

Pageof 25
Sort By:
Cancer Medicine|January 3, 2025
Serum 25-Hydroxyvitamin D Levels and Survival Outcomes in Advanced Biliary Tract Cancer: Results From the NIFTY TrialSo Heun Lee, Jaekyung Cheon, Ilhwan Kim, et al.
Cancer Chemotherapy and Pharmacology|June 25, 2009
Phase I/II and pharmacokinetic study of S-1 and oxaliplatin in previously untreated advanced gastric cancerInkeun Park, Jae-Lyun Lee, Min-Hee Ryu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2021
Kinetics of the neutrophil-lymphocyte ratio during PD-1 inhibition as a prognostic factor in advanced hepatocellular carcinomaWon-Mook Choi, Ji Yoon Kim, Jonggi Choi, et al.
Cancers|July 24, 2020
Effectiveness and Safety of Nivolumab in Child-Pugh B Patients with Hepatocellular Carcinoma: A Real-World Cohort StudyWon-Mook Choi, Danbi Lee, Ju Hyun Shim, et al.
Cancers|January 9, 2021
Feasibility of HER2-Targeted Therapy in Advanced Biliary Tract Cancer: A Prospective Pilot Study of Trastuzumab Biosimilar in Combination with Gemcitabine Plus CisplatinHyehyun Jeong, Jae Ho Jeong, Kyu-Pyo Kim, et al.
JHEP Reports : Innovation in Hepatology|March 9, 2026
Prognostic implications of tumour number in intrahepatic cholangiocarcinomaBrandon Lok-Hang Chan, Yan Li, YoungJae Kim, et al.
Digestive Diseases and Sciences|February 25, 2026
Using the EVendo Score to Predict Varices and Varices Needing Treatment in Hepatocellular Carcinoma Patients Planned for Atezolizumab-BevacizumabSuat Ying Lee, Chiew Woon Lim, Sejin Kim, et al.
Cancers|April 30, 2021
Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary ReviewChanghoon Yoo, Sang Hyun Shin, Joon-Oh Park, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 15, 2015
Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB-IV gastric cancerShinkyo Yoon, Changhoon Yoo, Min-Hee Ryu, et al.
Japanese Journal of Clinical Oncology|May 12, 2010
The efficacy and safety of sunitinib in korean patients with advanced renal cell carcinoma: high incidence of toxicity leads to frequent dose reductionChanghoon Yoo, Jeong Eun Kim, Jae-Lyun Lee, et al.
Pageof 25

Showing results (101-110 of 250) with videos related to

Sort By:
Pageof 25
Cancer Medicine|January 3, 2025
Serum 25-Hydroxyvitamin D Levels and Survival Outcomes in Advanced Biliary Tract Cancer: Results From the NIFTY TrialSo Heun Lee, Jaekyung Cheon, Ilhwan Kim, et al.
Cancer Chemotherapy and Pharmacology|June 25, 2009
Phase I/II and pharmacokinetic study of S-1 and oxaliplatin in previously untreated advanced gastric cancerInkeun Park, Jae-Lyun Lee, Min-Hee Ryu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2021
Kinetics of the neutrophil-lymphocyte ratio during PD-1 inhibition as a prognostic factor in advanced hepatocellular carcinomaWon-Mook Choi, Ji Yoon Kim, Jonggi Choi, et al.
Cancers|July 24, 2020
Effectiveness and Safety of Nivolumab in Child-Pugh B Patients with Hepatocellular Carcinoma: A Real-World Cohort StudyWon-Mook Choi, Danbi Lee, Ju Hyun Shim, et al.
Cancers|January 9, 2021
Feasibility of HER2-Targeted Therapy in Advanced Biliary Tract Cancer: A Prospective Pilot Study of Trastuzumab Biosimilar in Combination with Gemcitabine Plus CisplatinHyehyun Jeong, Jae Ho Jeong, Kyu-Pyo Kim, et al.
JHEP Reports : Innovation in Hepatology|March 9, 2026
Prognostic implications of tumour number in intrahepatic cholangiocarcinomaBrandon Lok-Hang Chan, Yan Li, YoungJae Kim, et al.
Digestive Diseases and Sciences|February 25, 2026
Using the EVendo Score to Predict Varices and Varices Needing Treatment in Hepatocellular Carcinoma Patients Planned for Atezolizumab-BevacizumabSuat Ying Lee, Chiew Woon Lim, Sejin Kim, et al.
Cancers|April 30, 2021
Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary ReviewChanghoon Yoo, Sang Hyun Shin, Joon-Oh Park, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 15, 2015
Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB-IV gastric cancerShinkyo Yoon, Changhoon Yoo, Min-Hee Ryu, et al.
Japanese Journal of Clinical Oncology|May 12, 2010
The efficacy and safety of sunitinib in korean patients with advanced renal cell carcinoma: high incidence of toxicity leads to frequent dose reductionChanghoon Yoo, Jeong Eun Kim, Jae-Lyun Lee, et al.
Pageof 25